Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Indoco Pharmchem Limited, was an unlisted public company incorporated on 26 June, 2012. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital was INR 5.00 lac and the total paid-up capital was INR 5.00 lac.
Indoco Pharmchem Limited's operating revenue range is Under INR 1 cr for the financial year ending on 31 March, 2017. It's book networth has decreased by 12.67%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR lacs. Based on March 2017 numbers.
-12.67%
-10.38%
-3.2
-3.18
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2015 | Mar 2016 | Mar 2017 | |
|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO |
| Networth | |||
| Borrowings | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO |
| Mar 2015 | Mar 2016 | Mar 2017 | |
|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO |
| Mar 2015 | Mar 2016 | Mar 2017 | |
|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO |
| Mar 2015 | Mar 2016 | Mar 2017 | |
|---|---|---|---|
| Solvency + | |||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||
| Current Ratio | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO |
| Performance | |||
| Gross Margin | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO |
| Return + | |||
| Return on Equity | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||
| Days Payable | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO |
| Working Capital | |||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sundeep Vasant Bambolkar | 00176613 | 12 years |
| Director | Aditi Milind Panandikar | 00179113 | 12 years |
| Director | Suresh Govind Kare | 00179220 | 12 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| WARREN PHARMACEUTICALS LIMITED |
Amalgamated
|
200.0 | 3 | Maharashtra |
| LA NOVA CHEM (INDIA) PRIVATE LIMITED |
Amalgamated
|
1.0 L | 3 | Maharashtra |
| SPA HOLDINGS PRIVATE LIMITED |
Active
|
62.0 L | 2 | Maharashtra |
| WARREN LABORATORIES LIMITED |
Amalgamated
|
0.0 | 3 | Maharashtra |
| SHREE HERBAL TECHNOLOGIES LIMITED |
Amalgamated
|
5.0 L | 3 | Delhi |
| XTEND INDUSTRIAL DESIGNERS AND ENGINEERS PRIVATE LIMITED |
Active
|
2.0 Cr | 2 | Maharashtra |
| INDOCO HEALTHCARE LIMITED |
Amalgamated
|
4.9 Cr | 3 | Himachal Pradesh |
| INDOCO ANALYTICAL SOLUTIONS LLP |
Strike Off
|
5.0 L | 1 | Maharashtra |
| INDOCO REMEDIES LIMITED |
Active
|
18.4 Cr | 3 | Maharashtra |
| WARREN REMEDIES PRIVATE LIMITED |
Active
|
15.0 Cr | 2 | Maharashtra |
| AMEYA PHARMACEUTICALS AND CHEMICALS PRIV ATE LIMITED |
Amalgamated
|
40.0 | 2 | Maharashtra |
| SHANTERI INVESTMENT PRIVATE LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
| INDOCO CAPITAL MARKETS LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
The incorporation date of INDOCO PHARMCHEM LIMITED is 26 June, 2012
The authorized share capital of INDOCO PHARMCHEM LIMITED is INR ₹ 5.0 L.
The paid-up capital of INDOCO PHARMCHEM LIMITED is INR ₹ 5.0 L.
The registered address of INDOCO PHARMCHEM LIMITED is INDOCO HOUSE 166 CST ROAD SANTACRUZ EAST MUMBAI Maharashtra - 400098
The CIN number of INDOCO PHARMCHEM LIMITED is U33112MH2012PLC232609.
Expand
Delete
Collapse
See
details
